ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $495,068,448 | -12.9% | 18,241,284 | -1.4% | 0.45% | -6.4% |
| Q2 2023 | $568,708,076 | -16.6% | 18,500,588 | -2.2% | 0.48% | -21.5% |
| Q1 2023 | $681,642,562 | +0.8% | 18,918,750 | +10.5% | 0.62% | -12.8% |
| Q4 2022 | $676,554,025 | -5.8% | 17,119,282 | -4.2% | 0.70% | -4.7% |
| Q3 2022 | $717,943,000 | -5.1% | 17,868,175 | -0.7% | 0.74% | -4.6% |
| Q2 2022 | $756,506,000 | +1622.9% | 17,994,918 | +1496.7% | 0.78% | +2403.2% |
| Q1 2022 | $43,909,000 | – | 1,127,031 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $263,446,000 | 59.92% |
| Memorial Sloan Kettering Cancer Center | 1,128,255 | $43,957,000 | 50.90% |
| Vantage Consulting Group Inc | 2,727,854 | $106,277,000 | 41.47% |
| Indie Asset Partners, LLC | 756,874 | $29,488,000 | 22.15% |
| Overbrook Management Corp | 723,250 | $28,178,000 | 6.25% |
| Brown University | 621,759 | $24,224,000 | 5.93% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $8,527,000 | 3.82% |
| Lagoda Investment Management, L.P. | 141,560 | $5,515,000 | 2.97% |
| Greytown Advisors Inc. | 131,143 | $5,109,000 | 2.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,025,610 | $78,918,000 | 2.41% |